The COVID-19 pandemic resulted in world-wide research efforts to better understand the disease-causing virus and its treatment options. There is a growing wealth of information on COVID-19 related to its research, clinical presentation, and treatment outcomes. This resource center, supported by Viatris provides in-depth learning of COVID-19 management from the experiences of clinical experts in the field and discusses established guidelines and the newer modalities in treatment. Speakers (>70) and medical associations (>20) from over 20 states of India have participated to provide a thorough understanding of disease management in their regions.
We welcome you to register for a live event opportunity or review a past recording.
IMA-Uttarakhand and IMA Himachal Pradesh welcome doctors to an interactive experience sharing recorded session on “Reinfection in COVID-19 patients; experience sharing and ex...
HIGHLIGHTS OF THE WEBINAR MODULE 1 - Overview of COVID-19, Dr B B Revari (30min) •Microbiology of corona virus, virus history with types and pathophysiology. •Description of t...
IMA Chandigarh welcomes you to recorded webinar session on “Treating Mild to Severe COVID-19 Patients” What was covered: Introduction of panelist: Dr. Mayuri Keskar, MLH & TC4A...
IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)" Intro...
Recording of the webinar is not available
Remdesivir , is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease....
As the incidence of COVID-19 cases continue to rise, we will need multiple approaches to effectively deal with this pandemic. Clinicians are evaluating Favipiravir for use in mild-to-moderat...
Indian Medical Association Rajasthan (IMA Raj) welcomes doctors to view a recorded session on “Clinical & Pulmonary COVID-19 complications” held on 13th Sep 2020, where...
Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge. Indian Medical Association Ma...
In India, Remdesivir has been approved for emergency use in patients hospitalized with severe COVID-19. There is a need to understand and share experience on the use of this drug. We welcome you to vi...
